PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
FOLD vs. USMV
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between FOLD and USMV is 0.31, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

FOLD vs. USMV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Amicus Therapeutics, Inc. (FOLD) and iShares Edge MSCI Min Vol USA ETF (USMV). The values are adjusted to include any dividend payments, if applicable.

-10.00%-5.00%0.00%5.00%10.00%15.00%AugustSeptemberOctoberNovemberDecember2025
-9.22%
6.24%
FOLD
USMV

Key characteristics

Sharpe Ratio

FOLD:

-0.77

USMV:

1.79

Sortino Ratio

FOLD:

-1.08

USMV:

2.51

Omega Ratio

FOLD:

0.88

USMV:

1.32

Calmar Ratio

FOLD:

-0.48

USMV:

2.57

Martin Ratio

FOLD:

-1.32

USMV:

8.41

Ulcer Index

FOLD:

23.39%

USMV:

1.85%

Daily Std Dev

FOLD:

40.07%

USMV:

8.69%

Max Drawdown

FOLD:

-89.91%

USMV:

-33.10%

Current Drawdown

FOLD:

-62.39%

USMV:

-6.04%

Returns By Period

In the year-to-date period, FOLD achieves a -0.64% return, which is significantly lower than USMV's -0.38% return. Over the past 10 years, FOLD has underperformed USMV with an annualized return of 0.57%, while USMV has yielded a comparatively higher 10.10% annualized return.


FOLD

YTD

-0.64%

1M

-3.80%

6M

-9.21%

1Y

-33.43%

5Y*

-0.65%

10Y*

0.57%

USMV

YTD

-0.38%

1M

-5.00%

6M

6.24%

1Y

14.67%

5Y*

7.91%

10Y*

10.10%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

FOLD vs. USMV — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FOLD
The Risk-Adjusted Performance Rank of FOLD is 1212
Overall Rank
The Sharpe Ratio Rank of FOLD is 1010
Sharpe Ratio Rank
The Sortino Ratio Rank of FOLD is 1010
Sortino Ratio Rank
The Omega Ratio Rank of FOLD is 1313
Omega Ratio Rank
The Calmar Ratio Rank of FOLD is 1818
Calmar Ratio Rank
The Martin Ratio Rank of FOLD is 1111
Martin Ratio Rank

USMV
The Risk-Adjusted Performance Rank of USMV is 7373
Overall Rank
The Sharpe Ratio Rank of USMV is 7474
Sharpe Ratio Rank
The Sortino Ratio Rank of USMV is 7474
Sortino Ratio Rank
The Omega Ratio Rank of USMV is 7373
Omega Ratio Rank
The Calmar Ratio Rank of USMV is 7575
Calmar Ratio Rank
The Martin Ratio Rank of USMV is 6868
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

FOLD vs. USMV - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Amicus Therapeutics, Inc. (FOLD) and iShares Edge MSCI Min Vol USA ETF (USMV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for FOLD, currently valued at -0.77, compared to the broader market-4.00-2.000.002.00-0.771.79
The chart of Sortino ratio for FOLD, currently valued at -1.08, compared to the broader market-4.00-2.000.002.004.00-1.082.51
The chart of Omega ratio for FOLD, currently valued at 0.88, compared to the broader market0.501.001.502.000.881.32
The chart of Calmar ratio for FOLD, currently valued at -0.48, compared to the broader market0.002.004.006.00-0.482.57
The chart of Martin ratio for FOLD, currently valued at -1.32, compared to the broader market-10.000.0010.0020.00-1.328.41
FOLD
USMV

The current FOLD Sharpe Ratio is -0.77, which is lower than the USMV Sharpe Ratio of 1.79. The chart below compares the historical Sharpe Ratios of FOLD and USMV, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.004.00AugustSeptemberOctoberNovemberDecember2025
-0.77
1.79
FOLD
USMV

Dividends

FOLD vs. USMV - Dividend Comparison

FOLD has not paid dividends to shareholders, while USMV's dividend yield for the trailing twelve months is around 1.68%.


TTM20242023202220212020201920182017201620152014
FOLD
Amicus Therapeutics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
USMV
iShares Edge MSCI Min Vol USA ETF
1.68%1.67%1.82%1.62%1.26%1.81%1.88%2.12%1.77%2.22%2.02%1.88%

Drawdowns

FOLD vs. USMV - Drawdown Comparison

The maximum FOLD drawdown since its inception was -89.91%, which is greater than USMV's maximum drawdown of -33.10%. Use the drawdown chart below to compare losses from any high point for FOLD and USMV. For additional features, visit the drawdowns tool.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-62.39%
-6.04%
FOLD
USMV

Volatility

FOLD vs. USMV - Volatility Comparison

Amicus Therapeutics, Inc. (FOLD) has a higher volatility of 11.81% compared to iShares Edge MSCI Min Vol USA ETF (USMV) at 2.94%. This indicates that FOLD's price experiences larger fluctuations and is considered to be riskier than USMV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%5.00%10.00%15.00%AugustSeptemberOctoberNovemberDecember2025
11.81%
2.94%
FOLD
USMV
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab